These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12487236)

  • 1. Factors associated with completion of a drug treatment court diversion program.
    Butzin CA; Saum CA; Scarpitti FR
    Subst Use Misuse; 2002; 37(12-13):1615-33. PubMed ID: 12487236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug treatment courts, British style: the drug treatment court movement in Britain.
    Bean P
    Subst Use Misuse; 2002; 37(12-13):1595-614. PubMed ID: 12487235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug treatment courts and the disease paradigm.
    Nolan JL
    Subst Use Misuse; 2002; 37(12-13):1723-50. PubMed ID: 12487240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juvenile drug treatment courts in the United States: initial lessons learned and issues being addressed.
    Cooper CS
    Subst Use Misuse; 2002; 37(12-13):1689-722. PubMed ID: 12487239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug treatment courts--a viable option for Canada? Sentencing issues and preliminary findings from the Toronto court.
    La Prairie C; Gliksman L; Erickson PG; Wall R; Newton-Taylor B
    Subst Use Misuse; 2002; 37(12-13):1529-66. PubMed ID: 12487233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emergence of drug treatment courts in Australia.
    Makkai T
    Subst Use Misuse; 2002; 37(12-13):1567-94. PubMed ID: 12487234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The challenges of conducting research in drug treatment court settings.
    Belenko S
    Subst Use Misuse; 2002; 37(12-13):1635-64. PubMed ID: 12487237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A decade of drug treatment court research.
    Turner S; Longshore D; Wenzel S; Deschenes E; Greenwood P; Fain T; Harrell A; Morral A; Taxman F; Iguchi M; Greene J; McBride D
    Subst Use Misuse; 2002; 37(12-13):1489-527. PubMed ID: 12487232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment inside the drug treatment court: the who, what, where, and how of treatment services.
    Taxman FS; Bouffard J
    Subst Use Misuse; 2002; 37(12-13):1665-88. PubMed ID: 12487238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dozen years of drug treatment courts: uncovering our theoretical foundation and the construction of a mainstream paradigm.
    Hora PF
    Subst Use Misuse; 2002; 37(12-13):1469-88. PubMed ID: 12487231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug treatment courts.
    Frescoln K
    N C Med J; 2009; 70(1):66-9. PubMed ID: 19534061
    [No Abstract]   [Full Text] [Related]  

  • 12. The dope on drug sentencing: new approaches simplify sentencing, get more drug abusers treatment and save states money.
    Lawrence A
    State Legis; 2011 Dec; 37(10):23-5. PubMed ID: 22187757
    [No Abstract]   [Full Text] [Related]  

  • 13. Introduction: Progress and issues in drug treatment courts.
    Harrison LD; Scarpitti FR
    Subst Use Misuse; 2002; 37(12-13):1441-67. PubMed ID: 12487230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptoms of depression and successful drug court completion.
    Mendoza NS; Trinidad JR; Nochajski TH; Farrell MC
    Community Ment Health J; 2013 Dec; 49(6):787-92. PubMed ID: 23325072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting drug court outcome among amphetamine-using participants.
    Wu LJ; Altshuler SJ; Short RA; Roll JM
    J Subst Abuse Treat; 2012 Jun; 42(4):373-82. PubMed ID: 22119183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Los Angeles County drug court programs: initial results.
    Fielding JE; Tye G; Ogawa PL; Imam IJ; Long AM
    J Subst Abuse Treat; 2002 Oct; 23(3):217-24. PubMed ID: 12392808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Client and program factors associated with dropout from court mandated drug treatment.
    Evans E; Li L; Hser YI
    Eval Program Plann; 2009 Aug; 32(3):204-12. PubMed ID: 19150133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary analysis of the Northern Territory's illicit drug court diversion program highlights the need to examine lower program completion rates for indigenous clients.
    Rysavy P; Cunningham T; O'Reilly-Martinez R
    Drug Alcohol Rev; 2011 Nov; 30(6):671-6. PubMed ID: 21355932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Criminal recidivism in three models of mandatory drug treatment.
    Young D; Fluellen R; Belenko S
    J Subst Abuse Treat; 2004 Dec; 27(4):313-23. PubMed ID: 15610833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating the drug-abusing offender.
    Leukefeld C; Matthews T; Clayton R
    J Ment Health Adm; 1992; 19(1):76-82. PubMed ID: 10171038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.